Back
3M Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
30
MMM
3M
Last Price:
126.27
Seasonality Move:
2.31%
Sell
37
SRPT
Sarepta Therapeutics
Last Price:
132.04
Seasonality Move:
9.41%
Sell
30
3M (MMM)
is a Sell
Is 3M a Buy, Sell or Hold?
- The current 3M [MMM] share price is $127.91. The Score for MMM is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- MMM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $129.88. The Score for SRPT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MMM Stock Price Chart
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $129.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
MMM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 31.66 | Sell |
| Chaikin Money Flow: | -2907028 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (133.01 - 137.21) | Sell |
| Bollinger Bands (100): | (105.36 - 134.78) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 59.84 | Buy |
| Chaikin Money Flow: | 345786 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.92 - 127.2) | Buy |
| Bollinger Bands (100): | (122.48 - 147.12) | Sell |
MMM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 134.03 | Sell |
| 20-day SMA: | 135.14 | Sell |
| 50-day SMA: | 132.68 | Sell |
| 200-day SMA: | 108.71 | Buy |
| 8-day EMA: | 133.02 | Sell |
| 20-day EMA: | 133.96 | Sell |
| 50-day EMA: | 130.58 | Sell |
| 200-day EMA: | 114.87 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 126.4 | Buy |
| 20-day SMA: | 123.6 | Buy |
| 50-day SMA: | 128.94 | Buy |
| 200-day SMA: | 130.02 | Sell |
| 8-day EMA: | 126.58 | Buy |
| 20-day EMA: | 125.36 | Buy |
| 50-day EMA: | 128.32 | Buy |
| 200-day EMA: | 127.84 | Buy |
3M Earnings Growth & MMM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.80 per share, and an increase next year of $0.62 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.27 per share, and an increase next year of $8.99 per share.
3M Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||